Veracyte (VCYT) Stock Forecast & Price Target
Score
Veracyte, Inc. price target
| VCYT | |
|---|---|
| Low | $44.00 |
| Average | $54.14 |
| High | $65.00 |
| Upside vs current price | +122.5% |
The average target of $54.14 is +122.5% versus the current VCYT price of $24.33.
Veracyte, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 2 |
| Buy | 9 |
| Hold | 1 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
12 analysts cover VCYT.
Veracyte, Inc. EPS and revenue estimates
Published annual figures for VCYT on this page are 2026 EPS $1.91, 2027 EPS $1.94. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $1.91 | $593.82M |
| 2027 | $1.94 | $660.03M |
Is Veracyte, Inc. a buy or sell?
Of the 12 analysts covering Veracyte, Inc., 11 rate it a buy (2 strong buy and 9 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The VCYT consensus label is Buy, beside 11 buy-side ratings and 0 sell-side ratings.
The average target of $54.14 implies +122.5% versus the current price of $24.33.
The VCYT rating block is 12 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the Veracyte, Inc. forecast
the Veracyte, Inc. is priced by the street between $44.00 and $65.00, average $54.14.
The gap from the $24.33 price to the VCYT average is +122.5%.
The VCYT rating mix is lopsided rather than split: 11 of 12 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.
The latest VCYT actions do not point one way: 0 up and 1 down.
The recent VCYT average ($46.00) is under the quarterly figure ($55.50).
With 12 analysts on VCYT, the average is a small sample.
Veracyte, Inc. forecast questions
What is the VCYT price target?
The published range for VCYT is $44.00 to $65.00, with an average of $54.14. That average is +122.5% versus the current price of $24.33.
Is Veracyte, Inc. a buy or sell?
Of the 12 analysts covering Veracyte, Inc., 11 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, leaving VCYT at 11 buy ratings, 1 holds, and 0 sells.
What is the EPS estimate for Veracyte, Inc.?
Analyst EPS estimates for Veracyte, Inc.: 2026 $1.91, 2027 $1.94.
What is the revenue estimate for Veracyte, Inc.?
Analyst revenue estimates for Veracyte, Inc.: 2026 $593.82M, 2027 $660.03M.
How many analysts cover VCYT?
12 analysts cover VCYT. Their consensus on VCYT is Buy, across those 12.